Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 15 April 1994:
Vol. 264. no. 5157, pp. 424 - 426
DOI: 10.1126/science.8153630
Prev | Table of Contents | Next

Articles

Science, Vol 264, Issue 5157, 424-426
Copyright © 1994 by American Association for the Advancement of Science

articles

Differential complementation of Bcr-Abl point mutants with c-Myc

DE Afar, A Goga, J McLaughlin, ON Witte, and CL Sawyers

Department of Microbiology and Molecular Genetics, University of California-Los Angeles 90024-1489.

A complementation strategy was developed to define the signaling pathways activated by the Bcr-Abl tyrosine kinase. Transformation inactive point mutants of Bcr-Abl were tested for complementation with c-Myc. Single point mutations in the Src-homology 2 (SH2) domain, the major tyrosine autophosphorylation site of the kinase domain, and the Grb-2 binding site in the Bcr region impaired the transformation of fibroblasts by Bcr-Abl. Hyperexpression of c-Myc efficiently restored transformation activity only to the Bcr-Abl SH2 mutant. These data support a model in which Bcr-Abl activates at least two independent pathways for transformation. This strategy may be useful for discerning signaling pathways activated by other oncogenes.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair.
M. S. Fernandes, M. M. Reddy, J. R. Gonneville, S. C. DeRoo, K. Podar, J. D. Griffin, D. M. Weinstock, and M. Sattler (2009)
Blood 114, 1813-1819
   Abstract »    Full Text »    PDF »
Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1.
J. Zhu, J. Blenis, and J. Yuan (2008)
PNAS 105, 6584-6589
   Abstract »    Full Text »    PDF »
c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.
H. Luo, Q. Li, J. O'Neal, F. Kreisel, M. M. Le Beau, and M. H. Tomasson (2005)
Blood 106, 2452-2461
   Abstract »    Full Text »    PDF »
Disruption of the Shc/Grb2 Complex during Abelson Virus Transformation Affects Proliferation, but Not Apoptosis.
L. B. Baughn and N. Rosenberg (2005)
J. Virol. 79, 2325-2334
   Abstract »    Full Text »    PDF »
Granulocyte-Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML.
C. H.M. Jamieson, L. E. Ailles, S. J. Dylla, M. Muijtjens, C. Jones, J. L. Zehnder, J. Gotlib, K. Li, M. G. Manz, A. Keating, et al. (2004)
N. Engl. J. Med. 351, 657-667
   Abstract »    Full Text »    PDF »
ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells.
T. Tamura, H. J. Kong, C. Tunyaplin, H. Tsujimura, K. Calame, and K. Ozato (2003)
Blood 102, 4547-4554
   Abstract »    Full Text »    PDF »
BCR/ABL-mediated Increased Expression of Multiple Known and Novel Genes That May Contribute to the Pathogenesis of Chronic Myelogenous Leukemia.
S. Salesse and C. M. Verfaillie (2003)
Mol. Cancer Ther. 2, 173-182
   Abstract »    Full Text »    PDF »
Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis.
M. Nieborowska-Skorska, G. Hoser, P. Kossev, M. A. Wasik, and T. Skorski (2002)
Blood 99, 4531-4539
   Abstract »    Full Text »    PDF »
Erythropoiesis in the absence of janus-kinase 2: BCR-ABL induces red cell formation in JAK2-/- hematopoietic progenitors.
S. Ghaffari, C. Kitidis, M. D. Fleming, H. Neubauer, K. Pfeffer, and H. F. Lodish (2001)
Blood 98, 2948-2957
   Abstract »    Full Text »    PDF »
Transformation of interleukin-3-dependent cells without participation of Stat5/bcl-xL: cooperation of akt with raf/erk leads to p65 nuclear factor {kappa}B-mediated antiapoptosis involving c-IAP2.
V. M. Gelfanov, G. S. Burgess, S. Litz-Jackson, A. J. King, M. S. Marshall, H. Nakshatri, and H. S. Boswell (2001)
Blood 98, 2508-2517
   Abstract »    Full Text »    PDF »
Temperature-Sensitive Transformation by an Abelson Virus Mutant Encoding an Altered SH2 Domain.
C. A. Mainville, K. Parmar, I. Unnikrishnan, L. Gong, G. D. Raffel, and N. Rosenberg (2001)
J. Virol. 75, 1816-1823
   Abstract »    Full Text »
The NH2-Terminal Coiled-Coil Domain and Tyrosine 177 Play Important Roles in Induction of a Myeloproliferative Disease in Mice by Bcr-Abl.
X. Zhang, R. Subrahmanyam, R. Wong, A. W. Gross, and R. Ren (2001)
Mol. Cell. Biol. 21, 840-853
   Abstract »    Full Text »
The Src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase.
S. Roumiantsev, I. E. de Aos, L. Varticovski, R. L. Ilaria, and R. A. Van Etten (2001)
Blood 97, 4-13
   Abstract »    Full Text »    PDF »
The SH2 domain of Bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype.
X. Zhang, R. Wong, S. X. Hao, W. S. Pear, and R. Ren (2001)
Blood 97, 277-287
   Abstract »    Full Text »    PDF »
The molecular biology of chronic myeloid leukemia.
M. W. N. Deininger, J. M. Goldman, and J. V. Melo (2000)
Blood 96, 3343-3356
   Full Text »    PDF »
The Carboxyl Terminus of v-Abl Protein Can Augment SH2 Domain Function.
D. Warren, A. J. Heilpern, K. Berg, and N. Rosenberg (2000)
J. Virol. 74, 4495-4504
   Abstract »    Full Text »
The Survival Function of the Bcr-Abl Oncogene Is Mediated by Bad-Dependent and -Independent Pathways: Roles for Phosphatidylinositol 3-Kinase and Raf.
M. S. Neshat, A. B. Raitano, H.-G. Wang, J. C. Reed, and C. L. Sawyers (2000)
Mol. Cell. Biol. 20, 1179-1186
   Abstract »    Full Text »
BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells.
S. Ghaffari, H. Wu, M. Gerlach, Y. Han, H. F. Lodish, and G. Q. Daley (1999)
PNAS 96, 13186-13190
   Abstract »    Full Text »    PDF »
BCR/ABL Directly Inhibits Expression of SHIP, an SH2-Containing Polyinositol-5-Phosphatase Involved in the Regulation of Hematopoiesis.
M. Sattler, S. Verma, C. H. Byrne, G. Shrikhande, T. Winkler, P. A. Algate, L. R. Rohrschneider, and J. D. Griffin (1999)
Mol. Cell. Biol. 19, 7473-7480
   Abstract »    Full Text »    PDF »
BCR/ABL mRNA and the P210BCR/ABL Protein Are Downmodulated by Interferon-alpha in Chronic Myeloid Leukemia Patients.
F. Pane, I. Mostarda, C. Selleri, R. Salzano, A. M. Raiola, L. Luciano, G. Saglio, B. Rotoli, and F. Salvatore (1999)
Blood 94, 2200-2207
   Abstract »    Full Text »    PDF »
The Biology of Chronic Myeloid Leukemia.
S. Faderl, M. Talpaz, Z. Estrov, S. O'Brien, R. Kurzrock, and H. M. Kantarjian (1999)
N. Engl. J. Med. 341, 164-172
   Full Text »    PDF »
Chronic Myeloid Leukemia.
C. L. Sawyers (1999)
N. Engl. J. Med. 340, 1330-1340
   Full Text »    PDF »
GCKR Links the Bcr-Abl Oncogene and Ras to the Stress-Activated Protein Kinase Pathway.
C.-S. Shi, J. M. Tuscano, O. N. Witte, and J. H. Kehrl (1999)
Blood 93, 1338-1345
   Abstract »    Full Text »    PDF »
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism.
C. V. Dang (1999)
Mol. Cell. Biol. 19, 1-11
   Full Text »    PDF »
The C-Terminus of c-Abl Is Required for Proliferation and Viability Signaling in a c-Abl/Erythropoietin Receptor Fusion Protein.
K. Okuda, A. D'Andrea, R.A. Van Etten, and J.D. Griffin (1998)
Blood 92, 3848-3856
   Abstract »    Full Text »    PDF »
Nucleic Acid Therapeutics: State of the Art and Future Prospects.
A. M. Gewirtz, D. L. Sokol, and M. Z. Ratajczak (1998)
Blood 92, 712-736
   Full Text »    PDF »
Fas-Mediated Modulation of Bcr/Abl in Chronic Myelogenous Leukemia Results in Differential Effects on Apoptosis.
C. Selleri, J. P. Maciejewski, F. Pane, L. Luciano, A. M. Raiola, I. Mostarda, F. Salvatore, and B. Rotoli (1998)
Blood 92, 981-989
   Abstract »    Full Text »    PDF »
Secondary Mutation Maintains the Transformed State in BaF3 Cells With Inducible BCR/ABL Expression.
K. M. Klucher, D. V. Lopez, and G. Q. Daley (1998)
Blood 91, 3927-3934
   Abstract »    Full Text »    PDF »
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation.
J. Y. Reuther, G. W. Reuther, D. Cortez, A. M. Pendergast, and A. S. Baldwin Jr. (1998)
Genes & Dev. 12, 968-981
   Abstract »    Full Text »
Identification and Characterization of Mutations in Ha-Ras That Selectively Decrease Binding to cRaf-1.
D. G. Winkler, J. C. Johnson, J. A. Cooper, and A. B. Vojtek (1997)
J. Biol. Chem. 272, 24402-24409
   Abstract »    Full Text »    PDF »
Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases..
X Zou, S Rudchenko, K Wong, and K Calame (1997)
Genes & Dev. 11, 654-662
   Abstract »    PDF »
A Coiled-coil Tetramerization Domain of BCR-ABL Is Essential for the Interactions of SH2-containing Signal Transduction Molecules.
T. Tauchi, K. Miyazawa, G.-S. Feng, H. E. Broxmeyer, and K. Toyama (1997)
J. Biol. Chem. 272, 1389-1394
   Abstract »    Full Text »    PDF »
The CRKL Adaptor Protein Transforms Fibroblasts and Functions in Transformation by the BCR-ABL Oncogene.
K. Senechal, J. Halpern, and C. L. Sawyers (1996)
J. Biol. Chem. 271, 23255-23261
   Abstract »    Full Text »    PDF »
Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family.
G. Reuther, H Fu, L. Cripe, R. Collier, and A. Pendergast (1994)
Science 266, 129-133
   Abstract »    PDF »
Genetic Approaches to Defining Signaling by the CML-associated Tyrosine Kinase BCR-ABL.
D.E.H. Afar, A. Goga, L. Cohen, C.L. Sawyers, J. McLaughlin, R.N. Mohr, and O.N. Witte (1994)
Cold Spring Harb Symp Quant Biol 59, 589-594
   Abstract »    PDF »
Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc.
R. C. Osthus, H. Shim, S. Kim, Q. Li, R. Reddy, M. Mukherjee, Y. Xu, D. Wonsey, L. A. Lee, and C. V. Dang (2000)
J. Biol. Chem. 275, 21797-21800
   Abstract »    Full Text »    PDF »
BCR/ABL Regulates Expression of the Cyclin-dependent Kinase Inhibitor p27Kip1 through the Phosphatidylinositol 3-Kinase/AKT Pathway.
F. Gesbert, W. R. Sellers, S. Signoretti, M. Loda, and J. D. Griffin (2000)
J. Biol. Chem. 275, 39223-39230
   Abstract »    Full Text »    PDF »
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis.
T. Bowman, M. A. Broome, D. Sinibaldi, W. Wharton, W. J. Pledger, J. M. Sedivy, R. Irby, T. Yeatman, S. A. Courtneidge, and R. Jove (2001)
PNAS 98, 7319-7324
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)